Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

Home CompaniesDaVita Inc.

DaVita Inc.

PortfolioPortfolio WatchlistWatchlist
Company price
181.17 GBX -3.69 ( 2.00%)
Last update at 2026-10-27T16:38:00Z
VOLUME
13
Market Cap
2478162.33M
P/E
0.17

Momentum Score

…

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
180.48
Low
185.39
High
52 Week Price Range
101.01
Low
160.00
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
184.86
Dividend Yield
-
Revenue TTM
13643.07M
Revenue Per Share
183.80
Gross Profit TTM
4400.59M
Debt / Equity
-23.12
ROE
64.85%
Net Debt
14292.24M
ROCE
13.44%
Diluted EPS TTM
8.46

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 1346.82M 1530.39M 1177.09M 966.28M 1518.49M
Net income 746.80M 936.34M 691.53M 546.95M 978.45M
Selling general administrative 1673.63M 1538.34M 1473.98M 1355.20M 1195.34M
Gross profit 3684.24M 4217.03M 3820.43M 3400.34M 3646.38M
Ebit 1926.75M 2000.86M 1575.64M 1312.54M 1770.43M
Ebitda 2642.10M 2724.72M 2321.09M 2045.14M 2451.05M
Depreciation and amortization 715.35M 723.86M 745.44M 732.60M 680.62M
Operating income 2010.62M 2090.48M 1602.78M 1312.54M 1770.43M
Other operating expenses 11632.45M 10725.07M 10537.36M 10274.86M 9820.56M
Interest expense 549.67M 470.47M 398.55M - 0.00M
Income tax expense 293.11M 279.66M 220.12M 198.09M 306.73M
Total revenue 13643.07M 12815.55M 12140.15M 11609.89M 11618.80M
Total operating expenses 1673.63M 2126.55M 2217.65M 2065.31M 1848.14M
Cost of revenue 9958.82M 8598.52M 8319.72M 8209.55M 7972.41M
Total other income expense net -663.79M -560.09M -425.69M -346.26M -251.94M
Discontinued operations - - - 13.45M 13.45M
Net income applicable to common shares - - - 560.40M 978.45M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 17480.10M 17285.27M 16893.58M 16928.25M 17121.49M
Intangible assets 222.12M 197.43M 203.22M 182.69M 177.69M
Other current assets 156.28M 207.84M 187.22M 592.32M 618.50M
Total liab 16321.66M 15193.92M 14150.23M 14703.45M 14750.51M
Total stockholder equity -651.08M 121.12M 1056.10M 712.33M 755.51M
Other current liab 1910.80M 1675.62M 1581.48M 2139.97M 1996.48M
Common stock 0.07M 0.09M 0.09M 0.09M 0.10M
Retained earnings -328.43M 1534.63M 598.29M 174.49M 354.34M
Other liab - - - 888.02M 950.11M
Good will 7545.10M 7375.22M 7112.56M 7076.61M 7046.24M
Other assets - -115.02M - 175.83M 124.47M
Cash 757.75M 794.93M 380.06M 244.09M 461.90M
Total current liabilities 3141.63M 2973.41M 2642.21M 2619.75M 2398.53M
Current deferred revenue - - 28.51M - -
Net debt 14292.24M 11271.90M 10736.36M -244.09M -461.90M
Short term debt 534.68M 681.28M 517.70M - -
Short long term debt total 15049.99M 12066.84M 11116.42M - -
Other stockholder equity -199.94M -1102.80M 509.80M 537.75M 401.07M
Property plant equipment - - - 5922.64M 6304.76M
Total current assets 4058.00M 3746.07M 3137.91M 3155.29M 3167.72M
Net tangible assets - - - -6546.97M -6468.43M
Short term investments 24.30M 51.06M 11.61M 77.69M 22.31M
Net receivables 2959.04M 2557.68M 2415.91M 2132.07M 1957.58M
Inventory 160.63M 134.56M 143.10M 109.12M 107.43M
Accounts payable 696.15M 547.20M 514.53M 479.78M 402.05M
Accumulated other comprehensive income -122.78M -310.80M -52.08M - -
Non currrent assets other 246.52M 261.73M 271.25M -13597.13M -13829.29M
Non current assets total 13422.10M 13539.20M 13755.67M 13597.13M 13829.29M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - - - -86.41M -16.94M
Change to liabilities - - - 87.48M -30.32M
Total cashflows from investing activities -654.95M -771.43M -771.80M -630.35M -784.73M
Net borrowings - - - -11.28M 754.25M
Total cash from financing activities -1374.78M -816.94M -1170.49M -1121.13M -1082.97M
Change to operating activities - - - 85.87M -14.82M
Net income 1078.72M 1250.74M 691.53M 560.40M 978.45M
Change in cash -122.08M 415.19M 125.64M -215.97M 53.17M
Begin period cash flow 879.83M 464.63M 338.99M 554.96M 501.79M
End period cash flow 757.75M 879.83M 464.63M 338.99M 554.96M
Total cash from operating activities 1886.50M 2022.04M 2059.03M 1564.57M 1930.88M
Depreciation 715.35M 723.86M 745.44M 732.60M 680.62M
Other cashflows from investing activities -36.34M 32.54M 35.52M -0.78M -0.74M
Change to inventory -19.95M 17.94M -32.13M -0.76M 5.72M
Change to account receivables -210.63M -29.77M 172.36M -148.39M -138.14M
Sale purchase of stock -1793.00M -1385.93M -272.22M -839.60M -1598.63M
Other cashflows from financing activities -374.69M -560.55M -362.56M 2122.86M 1376.78M
Change to netincome - - - 271.47M 412.45M
Capital expenditures 575.86M 555.44M 567.99M 603.43M 641.47M
Change in working capital -263.24M -29.82M 194.53M -149.15M -132.42M
Stock based compensation 139.95M 102.79M 112.38M 95.43M 102.21M
Other non cash items 129.15M 32.31M 354.50M 325.29M 302.02M
Free cash flow 1310.64M 1466.60M 1491.05M 961.14M 1289.41M

Peer Comparison*

Sector: Industry:

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
0I7E
DaVita Inc.		 -3.69
2.00%		 181.17 0.17 - 1.82 -
0R15
SoftBank Group Corp.		 248.00
5.84%		 4494.00 - - - -
0R1E
Nintendo Co. Ltd.		 -115.00
1.34%		 8476.00 - - - -
0LC3
Synchrony Financial		 2.34
3.20%		 75.60 0.09 - 4.97 -
0HQP
CBRE Group Inc. Cl A		 0.15
0.12%		 122.47 0.25 - 1.18 -

Profile*

DaVita Inc.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

2000 16th Street, Denver, CO, United States, 80202

720 631 2100

https://www.davita.com

78000

Name Title Year Born
Mr. Javier J. Rodriguez CEO & Exec. Director 1971
Mr. Joel Ackerman CFO & Treasurer 1965
Ms. Kathleen Alyce Waters Chief Legal & Public Affairs Officer 1968
Mr. James O. Hearty Chief Compliance Officer 1969
Mr. Michael David Staffieri Chief Operating Officer of Kidney Care 1974
Mr. John D. Winstel Chief Accounting Officer 1971
Mr. Jim Gustafson VP of Investor Relations NA
Mr. Kenneth Gardner Smith Chief People Officer 1981
Mr. Atul Mathur Exec. VP of Global Operations NA
Dr. Abdulkareem Alsuwaida FRCPC, M.D., MSc Chief Medical Officer - Saudi Operations NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

DAR
GBX 8.30
+23.42%
VTY
GBX 276.20
+8.23%
GTCO
GBX 0.09
+6.98%
GLV
GBX 2.34
+6.36%
BUR
GBX 249.20
+5.95%
TMI
GBX 0.72
-6.49%
HSBA
GBX 1291.40
-5.42%
RKT
GBX 5218.00
-4.85%
TGA
GBX 643.00
-4.03%
RKH
GBX 61.70
-3.89%

Equity Sectors*

  • Basic Materials

    -1.70%

  • Communication Services

    +0.33%

  • Consumer Cyclical

    +0.45%

  • Consumer Defensive

    -0.56%

  • Energy

    -0.25%

  • Financial Services

    +0.49%

  • Healthcare

    +0.20%

  • Industrials

    +0.74%

  • Real Estate

    +1.71%

  • Technology

    -2.81%

  • Utilities

    +0.28%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Cookies on this website

We use some essential cookies to make this site work. We also set analytics and marketing cookies, described below, to understand how you use the site and to measure our advertising. For more detailed information, see our Cookie Policy, Privacy Policy and Terms and Conditions.

Essential cookies

These cookies are necessary for core functionality, such as security, your shopping cart, remembering your cookie choice, and your progress through a report or free-trial request you started. They always need to be on.

Analytics cookies

We use analytics cookies to understand how visitors use the site — the pages visited, time spent, and where visitors came from.

Marketing cookies

These help us measure how effective our advertising is, such as recording actions you take after clicking one of our ads. If you don't enable this, you may still see our ads, but they won't be measured this way.

Support

Hi! How can we help you today?

Loading…